reducing postpartum exacerbations
Posted: Tue Feb 14, 2006 1:30 pm
Can anyone lead me to the latest on what, if anything, can be done to lessen the likelihood of an exacerbation after giving birth?
I found this article about a trial of intravenous immune globulin (IVIG) given at time of delivery, but it's from 2001:
http://www.medscape.com/viewarticle/413713
And this from the NMSS:
http://www.nationalmssociety.org/IMSApr03-MainEvent.asp
Mentions "an encouraging preliminary study on the use of IV immunoglobulin in the postpartum period to help prevent relapses for women who are off their disease-modifying drug while breastfeeding."
And this, from "Gender Specific Issues in MS"
http://72.14.207.104/search?q=cache:GWV ... clnk&cd=10
"The increased relapse rate postpartum has led to the issue of prophylactic therapy. In a recent study, nine MS patients with 12 previous childbirthassociated relapses received prophylactic intravenous immune globulin (IVIg) postpartum. None went on to have clinical relapses.98 In another study, eight women who received prophylactic IVIg were compared with 18 untreated women. Ten patients in the untreated group relapsed postpartum, compared with only one patient in the treated group.99 There is a current postpartum IVIg prophylaxis trial being conducted by the PRIMS study group. One hundred patients
are being randomized to receive a 10- or 60-gram IVIg load within 24 hours of delivery, followed by 10 grams monthly for 6 months. Clinical parameters, with the focus on relapse rate, are being measured. This study is based on preliminary data generated from 50 patients who were treated with IVIg. They had 66percent fewer postpartum relapses than would have been predicted."
But still, no results.
I found this article about a trial of intravenous immune globulin (IVIG) given at time of delivery, but it's from 2001:
http://www.medscape.com/viewarticle/413713
And this from the NMSS:
http://www.nationalmssociety.org/IMSApr03-MainEvent.asp
Mentions "an encouraging preliminary study on the use of IV immunoglobulin in the postpartum period to help prevent relapses for women who are off their disease-modifying drug while breastfeeding."
And this, from "Gender Specific Issues in MS"
http://72.14.207.104/search?q=cache:GWV ... clnk&cd=10
"The increased relapse rate postpartum has led to the issue of prophylactic therapy. In a recent study, nine MS patients with 12 previous childbirthassociated relapses received prophylactic intravenous immune globulin (IVIg) postpartum. None went on to have clinical relapses.98 In another study, eight women who received prophylactic IVIg were compared with 18 untreated women. Ten patients in the untreated group relapsed postpartum, compared with only one patient in the treated group.99 There is a current postpartum IVIg prophylaxis trial being conducted by the PRIMS study group. One hundred patients
are being randomized to receive a 10- or 60-gram IVIg load within 24 hours of delivery, followed by 10 grams monthly for 6 months. Clinical parameters, with the focus on relapse rate, are being measured. This study is based on preliminary data generated from 50 patients who were treated with IVIg. They had 66percent fewer postpartum relapses than would have been predicted."
But still, no results.